Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer
Phase 3 Unknown
290 enrolled
Electrochemotherapy for the Treatment of Vulvar Cancer
Phase NA Unknown
20 enrolled
Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Phase 2 Unknown
30 enrolled
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
Phase 1/2 Unknown
54 enrolled
PORTEC-3
Phase 3 Unknown
670 enrolled
Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy
Phase 2 Unknown
110 enrolled
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Phase 2 Unknown
165 enrolled 15 charts
Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
Phase 2 Unknown
36 enrolled
QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
Phase 3 Unknown
498 enrolled
A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
Phase 1 Unknown
30 enrolled
HIPEC After Initial CRS in Patients Who Have Received NACT
Phase 1 Unknown
15 enrolled
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Phase 3 Unknown
214 enrolled
Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
Phase NA Unknown
53 enrolled
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Phase 2 Unknown
63 enrolled 16 charts
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Phase 2 Unknown
57 enrolled 11 charts
A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
Phase 2 Unknown
20 enrolled
A Study of Carilizumab Combined With Concurrent Chemoradiotherapy
Phase 2 Unknown
46 enrolled
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Phase 3 Unknown
813 enrolled 14 charts
First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer
Phase 2 Unknown
172 enrolled
Combination Therapy for First Line Treatment of Advanced Cervical Cancer
Phase 1 Unknown
20 enrolled
A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
Phase 2 Unknown
46 enrolled
Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer
Phase 2 Unknown
35 enrolled
NANOCOL
Phase 1 Unknown
18 enrolled
Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer
Phase 2 Unknown
40 enrolled
How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix
Phase 2 Unknown
50 enrolled
SYSUGO-005
Phase NA Unknown
60 enrolled
Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer
Phase 2 Unknown
58 enrolled
FERMATA
Phase 3 Unknown
316 enrolled
VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical Cancer
Phase NA Unknown
15 enrolled
CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer
Phase 2 Unknown
82 enrolled
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)
Phase 2 Unknown
49 enrolled
Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer
Phase 1 Unknown
45 enrolled
TACO
Phase 3 Unknown
374 enrolled
COTI2-101
Phase 1 Unknown
51 enrolled
A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer
Phase NA Unknown
58 enrolled
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Phase 2 Unknown
100 enrolled
SYSGO-003
Phase 3 Unknown
700 enrolled
mEHT
Phase 3 Unknown
236 enrolled
A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer
Phase 3 Unknown
540 enrolled
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
Phase 2 Unknown
67 enrolled
Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer
Phase 2 Unknown
59 enrolled
Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer
Phase 3 Unknown
686 enrolled
CERVIPIB
Phase 3 Unknown
400 enrolled
Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients
Phase 3 Unknown
300 enrolled
Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients
Phase 3 Unknown
200 enrolled
Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer
Phase 3 Unknown
598 enrolled
Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer
Phase 2 Unknown
60 enrolled
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Phase 2 Unknown
100 enrolled
NACOPRAD
Phase 3 Unknown
534 enrolled
Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer
Phase 3 Unknown